PROSPERO AZ Pro00115490
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
AstraZeneca AB
Start Date
May 15, 2024
End Date
March 14, 2029
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
AstraZeneca AB
Start Date
May 15, 2024
End Date
March 14, 2029